Botox market Size was valued at USD 4.5 Billion in 2022. The botox market industry is projected to grow from USD 4.97 Billion in 2023 to USD 11.052 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.50% during the forecast period (2024 - 2032). The market's revenue growth is primarily being driven by market drivers such as the rising prevalence of chronic migraine and spasticity disorders, as well as the growing demand for aesthetic treatments.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The growing need for cosmetic procedures that are preventive is a major driver driving the growth of the botox industry. The worldwide market was driven by the surge in demand for anti-aging treatments that postpone the appearance of wrinkles and creases, particularly in younger people. Moreover, works well for preventive treatments in cosmetic operations to postpone or stop wrinkles and lines from forming before they get worse. Additionally, this method entails injecting wrinkle-prone areas to prevent muscle movement and lessen the appearance of lines brought on by repeated facial expressions. In addition, some people choose to have preventive procedures in their late 20s or early 30s as a proactive way to preserve their young appearance. Thus, during the forecast period, these factors are propelling the market's expansion.
The growing use of Botox in dentistry is one of the main reasons propelling the market expansion. Dentistry makes substantial usage of Botox. In addition, by relaxing the jaw muscles that cause teeth grinding, botox is a vital tool in the management of bruxism. Additionally, a lot of dentists have suggested it to patients with severe bruxism and temporomandibular jaw joint issues. In addition, it is frequently used to relieve tension in the muscles and mouth surrounding the teeth as well as to cure gummy smiles. Furthermore, the expanding use of botox in dentistry to treat trismus, extracapsular myogenic temporomandibular dysfunction, parafunctional cleaning, and the headaches associated with these diseases has led to its growing popularity. Thus, during the forecast period, these factors are propelling the market's expansion.
The products are utilized for indications that are both medicinal and cosmetic. The product's dual applicability increases consumer demand for them, which in turn propels the market's expansion. The market is growing because essential and chronic disorders such chronic migraine, cervical dystonia, and spasticity are becoming more common. For instance, a 2020 article from Johns Hopkins Medicine states that over 12 million people globally suffer with spasticity, with 80.0% of those afflicted by cerebral spasticity and 80.0% affected by multiple sclerosis. The expansion of the global market was also aided by the major pharmaceutical companies' growth in R&D endeavors to offer treatment alternatives for such crucial disorders. Thus, driving the botox market revenue.
The botox market segmentation, based on application includes Therapeutics (Chronic Migraine, Spasticity, Overactive Bladder, Cervical Dystonia, Blepharospasm, Others) and Aesthetics. The aesthetics segment dominated the market. The rising concern over appearance, in both developed and developing countries, has led to a rise in the need for cosmetic surgery. The availability of a wide range of products, such as Botox, Dysport, and Xeomin, among many others, will also expedite the growth of the market.
The botox market segmentation, based on type, includes Botulinum Toxin Type A and Botulinum Toxin Type B. The botulinum toxin type A category generated the most income due to a rise in patient choice brought about by benefits including less discomfort, no blood loss, and no scarring after the surgery. The use of botulinum toxin type-A is growing in the treatment of primary neurological diseases, tension-type headaches, and persistent migraines.
Figure 1: Botox market, by Type, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The botox market segmentation, based on end-user, includes Specialty & Dermatology Clinics, Hospitals & Clinics, and Others. The Specialty & Dermatology Clinics category generated the most income. Botulinum toxin's market income is expected to rise due to an increase in dermatological clinics in both developed and developing countries, resulting from increased demand for aesthetic procedures. The increased patient demand for dermatological clinics for cosmetic operations and cutting-edge amenities to enhance their visual appeal is a major contributing reason to the segmental expansion.
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American botox market area will dominate this market because there is a growing emphasis on beauty and a high demand for cosmetic operations. The presence of cutting-edge healthcare infrastructure and high levels of disposable income are two further factors propelling the market's revenue growth in this area.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: BOTOX MARKET SHARE BY REGION 2023 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe botox market accounts for the second-largest market share The region's aging population and the growing acceptance of cosmetic operations are the main drivers of the market's revenue growth. Additionally, it is anticipated that the presence of robust healthcare infrastructure and regulations in nations like Germany and France will further propel revenue growth in the European market. Further, the German botox market held the largest market share, and the UK botox market was the fastest growing market in the European region
The Asia-Pacific Botox Market is expected to grow at the fastest CAGR from 2023 to 2032. This is due to the rise in popularity of cosmetic procedures in nations like China, Japan, and South Korea where people place a great priority on appearance. Additionally, it is anticipated that the growing middle class and their high discretionary means will increase the need for botox in this area. Moreover, China’s botox market held the largest market share, and the Indian botox market was the fastest growing market in the Asia-Pacific region.
Botox Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the botox market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, botox industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global botox industry to benefit clients and increase the market sector. In recent years, the botox industry has offered some of the most significant advantages to medicine. Major players in the botox market are attempting to increase market demand by investing in research and development operations includes AbbVie Inc. (U.S.), Lanzhou Institute of Biological Products Co., Ltd. (China), Ipsen Pharma (France), Merz Pharma (Germany), Medytox (South Korea), GALDERMA (Switzerland), HUGEL, Inc. (South Korea), Evolus, Inc. (U.S.), Revance Therapeutics, Inc. (U.S.), and Supernus Pharmaceuticals, Inc. (U.S.).
AbbVie Inc. (AbbVie) is a specialty biopharmaceutical business that finds, develops, produces, and sells medications for the management of difficult-to-treat illnesses. Its medications are used to treat a variety of significant medical illnesses, including cancer, neurological disorders, skin ailments, rheumatoid arthritis, endometriosis-related pain, pediatric Crohn's disease, and rheumatological and metabolic diseases. Additionally, AbbVie is progressing its pipeline initiatives for the treatment of neurological disorders, autoimmune illnesses, wet AMD, viral diseases, Parkinson's disease, several malignancies, and cosmetic conditions.
Ipsen SA (Ipsen) is a multinational specialist biopharmaceutical firm that produces and distributes pharmaceutical goods, including specialty items, for the treatment of neurological disorders, cancer, other uncommon diseases. The company creates and markets innovative medications for neurological conditions, cancer, and uncommon illnesses. It also provides drugs to treat gastrointestinal issues and neurodegenerative diseases. In a few different countries, Ipsen sells its medications directly to hospitals as well as through a network of wholesalers.
Key Companies in the botox market include
Botox Industry Developments
October 2022: Galderma and National Breast Cancer Foundation Inc. maintained their collaboration (NBCF). During Breast Cancer Awareness Month, Galderma ran a social media campaign sharing the treatment journeys and personal stories of breast cancer survivors who got Sculptra, Dysport (abobotulinumtoxinA), or Restylane.
August 2022: Medytox and Bloomage Biotechnology have ended their collaboration. Since the joint venture agreement was signed, Medytox, according to Bloomage Biotechnology, has never offered Medybloom China BTX products for sale.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 4.5 Billion |
| Market Size 2023 | USD 4.97 Billion |
| Market Size 2032 | USD 11.052 Billion |
| Compound Annual Growth Rate (CAGR) | 10.50% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Application, Type, End-User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | AbbVie Inc. (U.S.), Lanzhou Institute of Biological Products Co., Ltd. (China), Ipsen Pharma (France), Merz Pharma (Germany), Medytox (South Korea), GALDERMA (Switzerland), HUGEL, Inc. (South Korea), Evolus, Inc. (U.S.), Revance Therapeutics, Inc. (U.S.), and Supernus Pharmaceuticals, Inc. (U.S.) |
| Key Market Opportunities | · Expanding Research and Development Efforts to Broaden Medical and Decorative Uses |
| Key Market Dynamics | · Growth in Interest in Non-Invasive Treatments · Raising Awareness via Important Players' Promotional Initiatives |
Frequently Asked Questions (FAQ) :
The botox market size was valued at USD 4.5 Billion in 2022.
The global market is projected to grow at a CAGR of 10.50% during the forecast period, 2024-2032.
North America had the largest share in the global market
The key players in the market are AbbVie Inc. (U.S.), Lanzhou Institute of Biological Products Co., Ltd. (China), Ipsen Pharma (France), Merz Pharma (Germany), Medytox (South Korea), GALDERMA (Switzerland), HUGEL, Inc. (South Korea), Evolus, Inc. (U.S.), Revance Therapeutics, Inc. (U.S.), amd Supernus Pharmaceuticals, Inc. (U.S.).
The aesthetics category dominated the market in 2022.
The Specialty & Dermatology Clinics category had the largest share in the global market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
